In addition, the plasma PACAP-38 levels of patients in groups AD and R were significantly lower compared to the control group (p (C vs. AD) < 0.0001, p (C vs. R) = 0.0170) (Figure 3). Here, ADCYAP1 is linked to Alzheimer disease.